| 氨沙坦比阿替洛尔更有效的降低患糖尿病的原发性高血压患者心血管疾病的发病率和死亡率 |
| |
| 作者姓名： | LindholmLH DahloefB IbsenH |
| |
| 作者单位： | CardiovascularmorbidityandmortalityinpatientswithdiabetesintheLosartanInterventionforEndpointreductioninhypertensionstudy(LIFE):arandomizedtrialagainstatenolol.Lancet2002Mar23:359:1004-10 |
| |
| 摘 要： | 问题:对患有糖尿病、原发性高血压并有左室肥厚征象的患者,以氯沙坦作为基础治疗是否比以阿替洛尔作为基础治疗更有效?
|
| 关 键 词： | 氨沙坦 阿替洛尔 糖尿病 原发性高血压 心血管疾病 发病率 死亡率 |
Losartan reduced cardiovascular morbidity and mortality more than atenolol in patients with diabetes and essential hypertension |
| |
| LindholmLH DahloefB IbsenH.Losartan reduced cardiovascular morbidity and mortality more than atenolol in patients with diabetes and essential hypertension[J].BMJ Chinese Edition,2003,6(2):117-118. |
| |
| Authors: | LindholmLH DahloefB IbsenH |
| |
| Institution: | CardiovascularmorbidityandmortalityinpatientswithdiabetesintheLosartanInterventionforEndpointreductioninhypertensionstudy(LIFE):arandomizedtrialagainstatenolol.Lancet2002Mar23:359:1004-10 |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 CNKI 维普 等数据库收录！ |
